Thomas Kohl1. 1. Department of Obstetrics and Prenatal Medicine, German Center for Fetal Surgery and Minimally Invasive Therapy, University of Bonn, Sigmund Freud Strasse 25, 53105 Bonn, Germany. thomas.kohl@ukb.uni-bonn.de
Abstract
BACKGROUND: The availability of high-end endoscopic equipment, microcatheters, miniballoons, tiny laser fibers, and other devices has been instrumental in the development of minimally invasive fetoscopic interventions. These interventions are performed for a spectrum of fetal disease states that progress in severity over the course of gestation and have a huge impact on termination of pregnancy rates, fetal demise, perinatal mortality and morbidity, and long-term prognosis. This report aims to introduce interested readers to these new procedures. METHODS: Fetoscopic interventions such as laser coagulation of pathologic placental vascular connections in twin-to-twin-transfusion-syndrome, fetal biopsies, fetal tracheal balloon occlusion in diaphragmatic hernia, perforation of posterior urethral valves, tracheal decompression in fetal laryngeal atresia, and even coverage of spina bifida aperta can be performed by percutaneous minimally invasive fetoscopic techniques. RESULTS: In contrast to prenatally untreated patients, the majority of patients who underwent fetoscopic interventions followed by state-of-the-art neonatal intensive care experienced improved survival rates and enhanced quality of life. Yet for some patients, significant morbidity from the underlying disease or fetal surgical complications, most often early preterm delivery, persist in postnatal life. CONCLUSION: A growing spectrum of fetal disease states has become amenable to minimally invasive fetoscopic interventions. Sufficient training, an interdisciplinary approach, ethical board supervision, and continued scientific assessment of benefits and risks are important for the success and acceptance of these procedures. Further improvements in fetal selection, surgical techniques, and postnatal management accompanied by the development of specialized devices are desired.
BACKGROUND: The availability of high-end endoscopic equipment, microcatheters, miniballoons, tiny laser fibers, and other devices has been instrumental in the development of minimally invasive fetoscopic interventions. These interventions are performed for a spectrum of fetal disease states that progress in severity over the course of gestation and have a huge impact on termination of pregnancy rates, fetal demise, perinatal mortality and morbidity, and long-term prognosis. This report aims to introduce interested readers to these new procedures. METHODS: Fetoscopic interventions such as laser coagulation of pathologic placental vascular connections in twin-to-twin-transfusion-syndrome, fetal biopsies, fetal tracheal balloon occlusion in diaphragmatic hernia, perforation of posterior urethral valves, tracheal decompression in fetal laryngeal atresia, and even coverage of spina bifida aperta can be performed by percutaneous minimally invasive fetoscopic techniques. RESULTS: In contrast to prenatally untreated patients, the majority of patients who underwent fetoscopic interventions followed by state-of-the-art neonatal intensive care experienced improved survival rates and enhanced quality of life. Yet for some patients, significant morbidity from the underlying disease or fetal surgical complications, most often early preterm delivery, persist in postnatal life. CONCLUSION: A growing spectrum of fetal disease states has become amenable to minimally invasive fetoscopic interventions. Sufficient training, an interdisciplinary approach, ethical board supervision, and continued scientific assessment of benefits and risks are important for the success and acceptance of these procedures. Further improvements in fetal selection, surgical techniques, and postnatal management accompanied by the development of specialized devices are desired.
Authors: Cleisson F A Peralta; Jacques C Jani; Dominique Van Schoubroeck; Kypros H Nicolaides; Jan A Deprest Journal: Am J Obstet Gynecol Date: 2007-09-12 Impact factor: 8.661
Authors: Margaret R Hüsler; R Douglas Wilson; Steven C Horii; Michael W Bebbington; N Scott Adzick; Mark P Johnson Journal: Prenat Diagn Date: 2009-05 Impact factor: 3.050
Authors: Bahig M Shehata; Jessica B Bare; Tiffany D Denton; Maria N Habib; Jennifer O Black Journal: Fetal Pediatr Pathol Date: 2006 May-Jun Impact factor: 0.958
Authors: Thomas Kohl; Ulrich Gembruch; Barbara Filsinger; Rudolf Hering; Jorgen Bruhn; Kristina Tchatcheva; Sebastian Aryee; Axel Franz; Axel Heep; Andreas Muller; Peter Bartmann; Stefan Loff; Stuart Hosie; Wolfgang Neff; Thomas Schaible Journal: Fetal Diagn Ther Date: 2006 Impact factor: 2.587
Authors: B W Paek; D L Farmer; C C Wilkinson; C T Albanese; W Peacock; M R Harrison; R W Jennings Journal: Am J Obstet Gynecol Date: 2000-11 Impact factor: 8.661
Authors: Mark Kilby; Khalid Khan; Katie Morris; Jane Daniels; Richard Gray; Laura Magill; Bill Martin; Peter Thompson; Zarko Alfirevic; Simon Kenny; Sarah Bower; Stephen Sturgiss; Dilly Anumba; Gerald Mason; Graham Tydeman; Peter Soothill; Karen Brackley; Pamela Loughna; Alan Cameron; Sailesh Kumar; Phil Bullen Journal: BJOG Date: 2007-07 Impact factor: 6.531
Authors: Jose L Peiro; Cesar G Fontecha; Rodrigo Ruano; Marielle Esteves; Carla Fonseca; Mario Marotta; Sina Haeri; Michael A Belfort Journal: Surg Endosc Date: 2013-05-14 Impact factor: 4.584